Skip to content

Urell and Pregnancy

Effect of URELL(Cranberry Vaccinium Macrocarpon)Consumption on the Prevalence of Recurrent Urinary Tract Infection and Asymptomatic Bacteriuria During Pregnancy.

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01818180
Enrollment
11
Registered
2013-03-26
Start date
2010-05-31
Completion date
Unknown
Last updated
2013-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Tract Infection (UTI)

Brief summary

Evaluation of the effect of URELL consumption on the occurrence of recurrent urinary tract infection (Acute cystitis, pyelonephritis and asymptomatic bacteriuria).

Interventions

DIETARY_SUPPLEMENTURELL
OTHERPlacebo

Sponsors

Hopital Foch
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

\- Pregnant woman in her 4th gestational month or more, having urinary tract infection.

Exclusion criteria

* Pregnant woman with organic or functional urinary tract malformations * Diabetic patients * HIV positive

Design outcomes

Primary

MeasureTime frame
Recurrence of Urinary tract infectionsFrom the 4th gestational month till the end of pregnancy (about the 40th gestational week)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026